A fusion peptide in preS1 and the human protein-disulfide isomerase ERp57 are involved in HBV membrane fusion process - CIRI - Virus enveloppés, Vecteurs, et Immunotherapie Access content directly
Journal Articles eLife Year : 2021

A fusion peptide in preS1 and the human protein-disulfide isomerase ERp57 are involved in HBV membrane fusion process

Abstract

Cell entry of enveloped viruses relies on the fusion between the viral and plasma or endosomal membranes, through a mechanism that is triggered by a cellular signal. Here we used a combination of computational and experimental approaches to unravel the main determinants of hepatitis B virus (HBV) membrane fusion process. We discovered that ERp57 is a host factor critically involved in triggering HBV fusion and infection. Then, through modelling approaches, we uncovered a putative allosteric cross-strand disulfide (CSD) bond in the HBV S glycoprotein and we demonstrate that its stabilization could prevent membrane fusion. Finally, we identified and characterized a potential fusion peptide in the preS1 domain of the HBV L glycoprotein. These results underscore a membrane fusion mechanism that could be triggered by ERp57, allowing a thiol/disulfide exchange reaction to occur and regulate isomerization of a critical CSD, which ultimately leads to the exposition of the fusion peptide.
Fichier principal
Vignette du fichier
elife-64507-v1.pdf (11.04 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

hal-03275938 , version 1 (01-07-2021)

Identifiers

Cite

Jimena Pérez-Vargas, Elin Teppa, Fouzia Amirache, Bertrand Boson, Rémi Pereira de Oliveira, et al.. A fusion peptide in preS1 and the human protein-disulfide isomerase ERp57 are involved in HBV membrane fusion process. eLife, 2021, 10, ⟨10.7554/eLife.64507⟩. ⟨hal-03275938⟩
168 View
96 Download

Altmetric

Share

Gmail Facebook X LinkedIn More